New research appears to show that a ketamine-based nasal spray can outmatch a standard option for people with treatment-resistant depression. The large clinical trial found that people taking the spray in combination with other antidepressants were more likely to experience a sustained remission of their symptoms than…
from Gizmodo https://ift.tt/YdSXtfe
via IFTTT https://ift.tt/o8kFhSv
No comments:
Post a Comment